Last reviewed · How we verify
conventional multifactorial therapy group
At a glance
| Generic name | conventional multifactorial therapy group |
|---|---|
| Sponsor | Xiang Guang-da |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Randomized Controlled Trial of a Web-based Platform for Cancer Pain Management (PHASE2)
- The Effect of Intensive Multifactorial Therapy on Endothelial Function in Newly Diagnosed Type 2 Diabetes (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |